Literature DB >> 21626145

Analysis of Escherichia coli isolated from patients affected by Crohn's disease.

Tiziana Raso1, Sabrina Crivellaro, Maria Gabriella Chirillo, Paolo Pais, Ezio Gaia, Dianella Savoia.   

Abstract

The etiopathogenesis of Crohn's disease (CD) is still controversial: several genetic, immunologic, and environmental factors, including some bacteria, have been implicated. This study has been devised to assess the involvement of Escherichia coli in CD. Seven E. coli strains were isolated from 14 biopsies obtained from ileocolic ulcers of patients affected by inflammatory bowel disease (IBD), including six with ulcerative colitis and eight with CD. Five strains, exclusively isolated from CD patients, were found inside mucosal cells. Different PCR techniques (for chuA, yjaA, TspE4.C2, escV, and bfpB genes) were performed and PFGE was carried out to characterize these bacteria in comparison with other E. coli strains isolated from non-IBD specimens. The correlation of these characters with bacterial invasiveness on intestinal (Caco-2) and phagocytic (U937) cells was assessed. Overall our pilot data suggest that five among eight strains isolated from CD patients belonged to the adherent-invasive E. coli (AIEC) group, and were invasive on Caco-2 cells and resistant to phagocytosis. These findings suggest that these bacteria could be considered target organisms whose elimination could reduce the intestinal inflammatory process and CD progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626145     DOI: 10.1007/s00284-011-9947-8

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  37 in total

Review 1.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

2.  Preliminary results obtained with cefoperazone plus corticosteroids in the treatment of active Crohn's disease.

Authors:  Ezio Gaia; Paolo Pais; Paola Salacone; Claudia Morello
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 4.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

5.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

6.  Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.

Authors:  Margarita Martinez-Medina; Xavier Aldeguer; Mireia Lopez-Siles; Ferran González-Huix; Carles López-Oliu; Ghizlane Dahbi; Jesus E Blanco; Jorge Blanco; L Jesus Garcia-Gil; Arlette Darfeuille-Michaud
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

Review 7.  Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.

Authors:  Cosimo Prantera; Maria Lia Scribano
Journal:  Curr Opin Gastroenterol       Date:  2009-07       Impact factor: 3.287

8.  Characterisation of atypical enteropathogenic E. coli strains of clinical origin.

Authors:  Sharon M Tennant; Marija Tauschek; Kristy Azzopardi; Andrea Bigham; Vicki Bennett-Wood; Elizabeth L Hartland; Weihong Qi; Thomas S Whittam; Roy M Robins-Browne
Journal:  BMC Microbiol       Date:  2009-06-03       Impact factor: 3.605

Review 9.  Role of bacteria in the etiopathogenesis of inflammatory bowel disease.

Authors:  Nicolas Barnich; Arlette Darfeuille-Michaud
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

10.  Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Authors:  Ben Willing; Jonas Halfvarson; Johan Dicksved; Magnus Rosenquist; Gunnar Järnerot; Lars Engstrand; Curt Tysk; Janet K Jansson
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

View more
  17 in total

1.  Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease.

Authors:  Nair Nazareth; Fernando Magro; Elisabete Machado; Teresa Gonçalves Ribeiro; António Martinho; Pedro Rodrigues; Rita Alves; Gonçalo Nuno Macedo; Daniela Gracio; Rosa Coelho; Candida Abreu; Rui Appelberg; Camila Dias; Guilherme Macedo; Tim Bull; Amélia Sarmento
Journal:  Med Microbiol Immunol       Date:  2015-05-21       Impact factor: 3.402

Review 2.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 3.  Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.

Authors:  Margarita Martinez-Medina; Librado Jesus Garcia-Gil
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Subversion of autophagy in adherent invasive Escherichia coli-infected neutrophils induces inflammation and cell death.

Authors:  Abderrahman Chargui; Annabelle Cesaro; Sanda Mimouna; Mohamed Fareh; Patrick Brest; Philippe Naquet; Arlette Darfeuille-Michaud; Xavier Hébuterne; Baharia Mograbi; Valérie Vouret-Craviari; Paul Hofman
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

5.  The role of autophagy in Crohn's disease.

Authors:  Paul Henderson; Craig Stevens
Journal:  Cells       Date:  2012-08-03       Impact factor: 6.600

Review 6.  Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.

Authors:  Allison Agus; Sébastien Massier; Arlette Darfeuille-Michaud; Elisabeth Billard; Nicolas Barnich
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

Review 7.  Why the discovery of adherent-invasive Escherichia coli molecular markers is so challenging?

Authors:  Carla Camprubí-Font; Margarita Martinez-Medina
Journal:  World J Biol Chem       Date:  2020-04-07

8.  Characteristics and pathogenic role of adherent-invasive Escherichia coli in inflammatory bowel disease: Potential impact on clinical outcomes.

Authors:  Jae Gon Lee; Dong Soo Han; Su Vin Jo; A Reum Lee; Chan Hyuk Park; Chang Soo Eun; Yangsoon Lee
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

9.  Genetic and Phenotypic Features to Screen for Putative Adherent-Invasive Escherichia coli.

Authors:  Carla Camprubí-Font; Christa Ewers; Mireia Lopez-Siles; Margarita Martinez-Medina
Journal:  Front Microbiol       Date:  2019-02-21       Impact factor: 5.640

10.  Increased S-nitrosylation and proteasomal degradation of caspase-3 during infection contribute to the persistence of adherent invasive Escherichia coli (AIEC) in immune cells.

Authors:  Karl A Dunne; Amr Allam; Anne McIntosh; Stephanie A Houston; Vuk Cerovic; Carl S Goodyear; Andrew J Roe; Scott A Beatson; Simon W Milling; Daniel Walker; Daniel M Wall
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.